IgA Fc-folate conjugate activates and recruits neutrophils to directly target triple-negative breast cancer cells.

Purpose: According to the American Cancer Society, 1 in 8 women in the U.S. will develop breast cancer, with triple-negative breast cancer (TNBC) comprising 15-20% of all breast cancer cases.